Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility

May 26, 2026Acta pharmacologica Sinica

Brain support cells’ alpha-2 receptors may help control daily changes in seizure risk

AI simplified

Abstract

Clozapine N-oxide (CNO) at a dose of 0.5 mg/kg elicited significantly more severe seizures during the light phase compared with the dark phase.

  • Circadian patterns in seizure susceptibility have been observed in patients with epilepsy.
  • Chemogenetic activation of the Gi pathway in hippocampal astrocytes reduced mild seizure occurrences specifically during the light phase.
  • Knockdown of adrenergic α2 receptors in astrocytes increased seizure susceptibility during the light phase, while administration of an α2 agonist partially reversed this effect.
  • Atipamezole, an α2 antagonist, enhanced lactate production in astrocytes, indicating a potential link between adrenergic signaling and metabolic responses.
  • Supplementing with medium-chain fatty acids in epileptic mice mitigated seizure exacerbation caused by α2 receptor knockdown, likely due to the production of ketone bodies.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free